LB Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 3.35 M | $82.68 M | 0.00% | 13.25% |
| BLACKROCK, INC. | 05/13/2026 | 2.47 M | $60.93 M | 10.36% | 9.77% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 2.21 M | $54.46 M | 0.00% | 8.73% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 1.84 M | $45.28 M | 5.41% | 7.27% |
| COMMODORE CAPITAL LP | 05/15/2026 | 1.50 M | $36.99 M | 0.00% | 5.93% |
| CALIGAN PARTNERS LP | 05/15/2026 | 1.44 M | $34.63 M | 100.00% | 5.68% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.43 M | $33.19 M | -11.41% | 5.64% |
| 05/14/2026 | 1.38 M | $33.64 M | 36.85% | 5.44% | |
| 05/15/2026 | 1.32 M | $32.54 M | -5.46% | 5.22% | |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.05 M | $25.96 M | 55.98% | 4.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 923.69 K | $22.78 M | 3.00% | 3.65% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 915.00 K | $22.56 M | -23.75% | 3.62% |
| 05/15/2026 | 894.65 K | $22.06 M | 100.00% | 3.54% | |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 863.95 K | $21.28 M | 27.99% | 3.41% |
| VIVO CAPITAL, LLC | 05/20/2026 | 800.00 K | $19.73 M | 0.00% | 3.16% |
| NAN FUNG GROUP HOLDINGS LTD | 05/14/2026 | 630.66 K | $15.55 M | 110.22% | 2.49% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 538.22 K | $13.27 M | -34.51% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 518.23 K | $12.78 M | 17.39% | 2.05% |
| STATE STREET CORP | 05/15/2026 | 504.37 K | $12.44 M | 101.73% | 1.99% |
| CITADEL ADVISORS LLC | 05/15/2026 | 416.91 K | $10.28 M | 2.27% | 1.65% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 363.80 K | $8.97 M | 20.02% | 1.44% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 300.00 K | $7.40 M | 100.00% | 1.19% |
| FMR LLC | 05/15/2026 | 222.51 K | $5.49 M | 0.29% | 0.88% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 200.00 K | $4.93 M | 0.00% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 186.10 K | $4.59 M | 4.77% | 0.74% |
| HIGHVISTA STRATEGIES LLC | 05/15/2026 | 173.60 K | $4.28 M | 23.90% | 0.69% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 157.43 K | $3.88 M | 100.00% | 0.62% |
| NORTHERN TRUST CORP | 05/14/2026 | 154.40 K | $3.81 M | 7.25% | 0.61% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 150.00 K | $3.70 M | 50.00% | 0.59% |
| UBS GROUP AG | 05/05/2026 | 137.93 K | $3.40 M | 171.99% | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 136.97 K | $3.38 M | 100.00% | 0.54% |
| 05/08/2026 | 112.50 K | $2.77 M | 100.00% | 0.44% | |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 108.31 K | $2.67 M | -44.04% | 0.43% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 100.20 K | $2.47 M | 100.00% | 0.40% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 72.07 K | $1.78 M | 4,625.70% | 0.28% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 70.00 K | $1.73 M | 0.00% | 0.28% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 65.43 K | $1.61 M | 100.00% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 52.64 K | $1.30 M | 100.00% | 0.21% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 50.00 K | $1.23 M | 100.00% | 0.20% |
| MORGAN STANLEY | 05/15/2026 | 47.28 K | $1.17 M | 91.88% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 45.46 K | $1.12 M | 12.19% | 0.18% |
| ACUTA CAPITAL PARTNERS, LLC | 05/15/2026 | 28.92 K | $713.14 K | -3.60% | 0.11% |
| CALAMOS ADVISORS LLC | 05/04/2026 | 24.06 K | $593.39 K | 100.00% | 0.10% |
| NUVEEN, LLC | 04/30/2026 | 22.97 K | $566.34 K | 0.00% | 0.09% |
| COLONY GROUP, LLC | 05/15/2026 | 19.82 K | $488.64 K | -1.39% | 0.08% |
| RHUMBLINE ADVISERS | 05/12/2026 | 17.10 K | $421.75 K | 5.04% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 16.62 K | $409.80 K | -62.02% | 0.07% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 15.36 K | $378.75 K | 15.50% | 0.06% |
| MEYER HANDELMAN CO | 04/20/2026 | 15.09 K | $372.22 K | 100.00% | 0.06% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 14.51 K | $357.72 K | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LB Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 86 institutional investors and hedge funds held shares of LB Pharmaceuticals Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 3.35 M
BlackRock, Inc.: 2.47 M
RA CAPITAL MANAGEMENT, L.P.: 2.21 M
TCG Crossover Management, LLC: 1.84 M
COMMODORE CAPITAL LP: 1.5 M
Caligan Partners LP: 1.44 M
111.50% of LB Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 25.69 M shares in the last 24 months. This purchase volume represents approximately $625.26 M in transactions.